Suresh Singh

Suresh Singh has a diverse and extensive work experience in various pharmaceutical and biotech companies. Suresh started their career at Wyeth-Ayerst Research as a Senior Scientist in 1993 and later joined Merck as a Research Fellow in 1996. In 2004, they moved to Vitae Pharmaceuticals and held roles as Director of Computational Drug Design and later as Senior Director till 2017. After working briefly as an Executive Director at Allergan in 2017, they joined HotSpot Therapeutics, Inc. as a Vice President until 2018. From 2019 to 2022, they served as an Advisor at Charm Ventures and Rasio Therapeutics, Inc. In 2020, they worked at Claim Therapeutics LLC as the Head of Computational and Modeling. Since 2021, they have been serving as the Senior Vice President of Computational Sciences at Matchpoint Therapeutics.

Suresh Singh completed their education in a chronological order. Suresh started their educational journey in 1981 at the Indian Institute of Technology, Kanpur, where they pursued a Master of Science degree in Chemistry. From 1984 to 1987, they attended Boston University, where they earned a Master of Science degree in Biochemistry. Following this, they pursued a Ph.D. in Computational Chemistry at New York University from 1987 to 1991. Lastly, Suresh Singh engaged in a post-doctoral program at the University of California, San Francisco, specializing in Computational Chemistry from 1991 to 1993.